TH and THTX Related Headlines

Apr 11, 2024 07:30AM Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Mar 22, 2024 09:37AM Theratechnologies (THTX) Issues Update on Preclinical Oncology Research Program

Mar 22, 2024 09:36AM Theratechnologies Announces Update on its Preclinical Oncology Research Program

Mar 21, 2024 07:30AM Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Dec 21, 2023 04:09PM Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

Oct 31, 2023 12:34PM Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement

Sep 18, 2023 04:15PM Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update

Sep 7, 2023 01:57PM Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 30, 2023 10:34AM Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide

Aug 21, 2023 03:24PM Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite

Jul 21, 2023 07:00AM Theratechnologies Announces the Resignation of One of Its Directors, Mr. Gary Littlejohn

Jun 12, 2023 07:30AM Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial

Jun 2, 2023 12:15PM Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide

May 25, 2023 05:31PM Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023

May 9, 2023 12:01PM Theratechnologies Reports on its Annual Meeting of Shareholders

TH and THTX Related Press Releases

Apr 11, 2024 07:30AM Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Mar 22, 2024 09:36AM Theratechnologies Announces Update on its Preclinical Oncology Research Program

Mar 21, 2024 07:30AM Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Dec 21, 2023 04:09PM Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

Oct 31, 2023 12:34PM Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement

Sep 18, 2023 04:15PM Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update

Sep 7, 2023 01:57PM Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 30, 2023 10:34AM Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide

Aug 21, 2023 03:24PM Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite

Jul 21, 2023 07:00AM Theratechnologies Announces the Resignation of One of Its Directors, Mr. Gary Littlejohn

Jun 12, 2023 07:30AM Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial

Jun 2, 2023 12:15PM Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide

May 25, 2023 05:31PM Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023

May 9, 2023 12:01PM Theratechnologies Reports on its Annual Meeting of Shareholders

TH and THTX Related SEC Filings

Apr 15, 2024 09:31AM Form 6-K Theratechnologies Inc. For: Apr 15

Apr 10, 2024 08:31AM Form 6-K Theratechnologies Inc. For: Apr 10

Apr 10, 2024 08:17AM Form 6-K Theratechnologies Inc. For: Apr 10

Apr 5, 2024 12:58PM Form 6-K Theratechnologies Inc. For: Apr 05

Mar 22, 2024 04:27PM Form 6-K Theratechnologies Inc. For: Mar 22

Mar 22, 2024 01:38PM Form 6-K Theratechnologies Inc. For: Mar 22

Mar 21, 2024 12:40PM Form 6-K Theratechnologies Inc. For: Mar 21

Feb 29, 2024 04:56PM Form 6-K Theratechnologies Inc. For: Feb 29

Feb 27, 2024 08:38AM Form 6-K Theratechnologies Inc. For: Feb 27

Feb 21, 2024 08:02AM Form 20-F Theratechnologies Inc. For: Nov 30

Feb 21, 2024 08:00AM Form 6-K Theratechnologies Inc. For: Feb 21

Feb 15, 2024 08:38AM Form 6-K Theratechnologies Inc. For: Feb 15

Feb 14, 2024 04:52PM Form SC 13G Theratechnologies Inc. Filed by: Nantahala Capital Management, LLC

Feb 7, 2024 06:55PM Form SC 13G/A Theratechnologies Inc. Filed by: HIRSCHMAN ORIN

Feb 6, 2024 02:30PM Form 6-K Theratechnologies Inc. For: Feb 06

Feb 1, 2024 11:51AM Form 6-K Theratechnologies Inc. For: Feb 01

Jan 24, 2024 01:52PM Form 6-K Theratechnologies Inc. For: Jan 24

Jan 23, 2024 02:02PM Form 6-K Theratechnologies Inc. For: Jan 23

Jan 4, 2024 06:03AM Form EFFECT Theratechnologies Inc.

Jan 2, 2024 04:28PM Form F-3/A Theratechnologies Inc.

Dec 21, 2023 04:25PM Form 6-K Theratechnologies Inc. For: Dec 21

Dec 21, 2023 01:22PM Form F-3 Theratechnologies Inc.

Dec 13, 2023 02:42PM Form 6-K Theratechnologies Inc. For: Dec 13

Nov 29, 2023 04:34PM Form SC 13G Theratechnologies Inc. Filed by: HIRSCHMAN ORIN

Nov 28, 2023 04:53PM Form SC 13D Theratechnologies Inc. Filed by: Soleus Capital Master Fund, L.P.

Nov 13, 2023 04:10PM Form SC 13D Theratechnologies Inc. Filed by: Investissement Quebec

Nov 6, 2023 01:18PM Form 6-K Theratechnologies Inc. For: Nov 06

Nov 6, 2023 12:29PM Form 6-K Theratechnologies Inc. For: Nov 06

Nov 3, 2023 02:27PM Form 6-K Theratechnologies Inc. For: Nov 03

Oct 31, 2023 12:52PM Form 6-K Theratechnologies Inc. For: Oct 31

Oct 27, 2023 06:09AM Form SUPPL Theratechnologies Inc.

Oct 27, 2023 06:05AM Form 6-K Theratechnologies Inc. For: Oct 26

Oct 26, 2023 09:51AM Form 6-K Theratechnologies Inc. For: Oct 26

Oct 26, 2023 06:02AM Form F-X Theratechnologies Inc. Filed by: Theratechnologies Inc.

Oct 26, 2023 06:02AM Form SUPPL Theratechnologies Inc.

Oct 26, 2023 06:01AM Form 6-K Theratechnologies Inc. For: Oct 25

Oct 24, 2023 02:47PM Form 6-K Theratechnologies Inc. For: Oct 24

Oct 24, 2023 08:25AM Form 6-K Theratechnologies Inc. For: Oct 24

Oct 16, 2023 03:05PM Form 6-K Theratechnologies Inc. For: Oct 16

Sep 26, 2023 08:03AM Form 6-K Theratechnologies Inc. For: Sep 26

Sep 26, 2023 08:01AM Form 6-K Theratechnologies Inc. For: Sep 26

Sep 25, 2023 03:33PM Form 6-K Theratechnologies Inc. For: Sep 25

Sep 25, 2023 11:41AM Form 6-K Theratechnologies Inc. For: Sep 25

Jul 31, 2023 11:13AM Form 6-K Theratechnologies Inc. For: Jul 31

Jul 28, 2023 05:20PM Form 6-K Theratechnologies Inc. For: Jul 28

Jul 27, 2023 02:55PM Form 6-K Theratechnologies Inc. For: Jul 27

Jul 20, 2023 08:01AM Form 6-K Theratechnologies Inc. For: Jul 20

Jul 12, 2023 08:03AM Form 6-K Theratechnologies Inc. For: Jul 12

Jul 12, 2023 08:01AM Form 6-K Theratechnologies Inc. For: Jul 12

Jun 22, 2023 10:17AM Form 6-K Theratechnologies Inc. For: Jun 22

Jun 22, 2023 08:02AM Form 6-K Theratechnologies Inc. For: Jun 22

Jun 2, 2023 01:03PM Form 6-K Theratechnologies Inc. For: Jun 02

May 10, 2023 03:48PM Form 6-K Theratechnologies Inc. For: May 10

May 9, 2023 02:49PM Form 6-K Theratechnologies Inc. For: May 09